Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromocriptine, Metoprolol and Tamsulosin in Non-Central DME
NCT03384524Phase 2Withdrawn
- Start
- Mar 2018
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of bromocriptine, metoprolol, tamsulosin in diabetic macular edema (DME). Planned start Mar 2018; status: withdrawn.
02
Drugs
bromocriptinemetoprololtamsulosin
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03384524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03384524.